BioMed Realty Trust CEO Discusses Q2 2012 Results - Earnings Call Transcript

BioMed Realty Trust, Inc. (BMR)

Q2 2012 Earnings Call

August 1, 2012 12:00 p.m. ET

Executives

Rick Howe - Director of Corporate Communications

Alan Gold - CEO

Greg Lubushkin - CFO

Kent Griffin – President

Matt McDevitt - EVP, Real Estate

Analysts

Chris Katen - Morgan Stanley

Brendan Maiorana – Wells Fargo Securities, LLC

Tayo Okusanya - Jefferies

John Stewart - Green Street Advisors

Ross Nussbaum - UBS

Rich Anderson – BMO Capital Markets

Rob Stephenson - Macquarie

Presentation

Operator

Welcome to the Q2 2012 BioMed Realty Trust Incorporated Earnings Conference Call. My name is Christine and I will be your operator for today’s call. (Operator Instructions)

I will now turn the call over to Rick Howe, Senior Director of Corporate Communications. Rick, you may begin.

Rick Howe

Thank you, Christine, and welcome, everyone. Today’s second quarter 2012 earnings call includes a slide presentation to accompany our prepared remarks. If you are not currently viewing the slides and would like to, please go to www.biomedrealty.com, click on the investor relations tab on the left and then click the Q2 2012 BioMed Realty Trust, Inc. earnings conference call link. We have also posted these slides on the investor relations tab of our website under the title “Investor Presentation August 2012.”

Presenting today are Alan Gold, Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President of Real Estate, and Greg Lubushkin, Chief Financial Officer.

Before we begin, I would like to remind everyone of the Safe Harbor statement included in yesterday’s news release. The Private Securities Litigation Reform Act of 1995 provides a Safe Harbor for certain forward-looking statement, including statements made during the course of today’s conference call. These forward-looking statements are based on the company’s current expectations, and involve significant risks and uncertainties, some of which are beyond the control of the company, and are subject to change based on various factors. Actual results may differ materially from those expressed or implied in the forward-looking statements. For a detailed discussion of some of the ongoing risks and uncertainties of the company’s business, I refer you to the news release issued yesterday and filed with the SEC on form 8-K, as well as the company’s other SEC filings including its most recent annual report on form 10-K and quarterly reports on form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

If you liked this article you might like

BioMed Realty (BMR) Marked As A Barbarian At The Gate

3 Hold-Rated Dividend Stocks: SEAS, BMR, TGH

3 Real Estate Stocks Moving The Industry Upward

BioMed Realty Just One of Blackstone's Latest Multi-Billion-Dollar Deals

Jim Cramer -- REIT Sector Hammered but Still Buying Opportunities